Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Some customer data stolen in cyberattack, M&S reveals

(Sharecast News) - High street stalwart Marks & Spencer revealed on Tuesday that customer information was stolen in the cyberattack that hit operations three weeks ago. The company, which still has a pause on all online orders and its click and collect service since the cyber incident was first reported on 22 April, said the "some" of customers' personal data was taken by hackers "due to the sophisticated nature of the incident".

"The personal data taken could include contact details - such as name, email address, addresses, telephone number - date of birth, online order history, household information and 'masked' payment card details used for online purchases," M&S said in an FAQ section on its website.

However, the company stressed that the stolen data does not include "useable" payment or card details, which it does not hold on our systems, or any account passwords.

There is also no evidence that this data has been shared, it said, informing customers that no action was needed.

"For extra peace of mind, they will be prompted to reset their password the next time they visit or log onto their M&S account and we have shared information on how to stay safe online," the retailer said.

Shares in the high street firm, while up 1% on Tuesday, have fallen by around 15% since the incident was first reported.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.